New-onset hyperglycaemia and prolonged systemic corticosteroids therapy in mild COVID-19 patients as major risk factors for invasive mucormycosis: a preliminary study

BACKGROUND AND PURPOSE: Rapid surge of invasive mucormycosis has surprised the Indian healthcare system amidst the coronavirus disease-19 (COVID-19) pandemic. Hence, there is an urgent need to find the risk factors for the sudden rise in cases of invasive mucormycosis among COVID-19 patients. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Khichar, Satyendra, Samantaray, Subhashree, Kumar, Deepak, Mobarsa, Veena, Jain, Vidhi, Sharma, Vidhu, Soni, Kapil, Choudhury, Bikram, Goyal, Amit, Shankar Meena, Durga, Srinivasan, Srikanth, Dutt, Naveen, Bhardwaj, Pankaj, Agarwal, Ashwini, Kumar Garg, Mahendra, Misra, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Medical Mycology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006735/
https://www.ncbi.nlm.nih.gov/pubmed/35528622
http://dx.doi.org/10.18502/CMM.7.3.7254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006735/
https://www.ncbi.nlm.nih.gov/pubmed/35528622
http://dx.doi.org/10.18502/CMM.7.3.7254

Ejemplares similares